Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma

Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone

Ten years of hormone therapy reduces breast cancer recurrence without compromising quality of life

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Novel daratumumab-based regimen slows multiple myeloma progression

Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma

Advanced hepatocellular carcinoma and personalised therapy

Latest in hepatocellular carcinoma treatments

Liquid biopsy may help guide treatment decisions for advanced solid tumours